Introduction
Amongst all the bones, sternum is the least common bone to get affected by tuberculosis (TB). Out of all skeletal TB, only 1% involves the sternum. 1 Even though TB is a common infective complication in solid organ transplant recipients especially in developing countries, yet sternal TB seems to be rare. We have described a renal transplant recipient who presented with a chest swelling diagnosed as sternal TB. To the best of our knowledge, this may be the first such case reported in a renal transplant recipient.
Case report
A 55-year-old woman, a live related donor renal transplant recipient since 2008, etiology of CKD undetermined, presented with painless swelling over the upper part of the chest below the left clavicle gradually increasing since 10 days. The patient denied any h/o trauma to site or any surgical intervention. Also, there was no h/o fever or night sweats, or prior TB. The patient had decreased appetite since 10 days. She till then was on regular stable triple immunosuppression including Tacrolimus, MMF, and Prednisone with stable graft function. On examination, she had a 3 cm Â 3 cm fluctuant painless swelling below the left clavicle and involving upper 1/3rd of sternum with no tenderness, redness, or discharge or fistula or sinuses. Evaluation revealed hemoglobin of 10.7 gm/dl, normal total leukocyte count 8910/mm 3 , BUN 12 mg/dl and serum creatinine 0.8 mg/dl, and ESR of 90 mm. Tuberculin skin test was negative. Tacrolimus level was 5.6 ng/ml. Chest X-ray showed aortic knuckle calcification and otherwise was reported normal. MRI of the chest showed a lytic destructive lesion in the superior portion of manubrium sterni on left side with large soft tissue component extending peripherally from i n d i a n j o u r n a l o f t r a n s p l a n t a t i o n 9 ( 2 0 1 5 ) 1 5 2 - 
Discussion
Mycobacterium TB is a serious opportunistic infection in solid organ transplant recipients. The TB incidence is 20-74 times greater than that among the general population. García-Goez et al. found that in solid organ transplants pulmonary TB represented 47.6% of cases; extrapulmonary 28.6%; and disseminated 23.8% of all affected by TB. 2 Spine and hip are more susceptible to TB whereas sternum is resistant to infections and an infrequent site for osteomyelitis. Pyogenic affection of the sternum is more common, especially due to staphylococcus compared to TB even in endemic countries. 3 Median onset of TB in renal allograft recipients has been shown to be 26 months; however, Atasaver et al. proved that immunosuppression with tacrolimus or mycophenolate has been associated with the development of TB much earlier in the post-transplantation period and also in younger patients. 4 However, in our patient it occurred after 5 years of stable immunosuppression and graft function. Sternal TB is predominantly seen in middle-aged adults although it could occur at any age. 5 It can arise primarily due to hematogenous route or direct extension from the hilar lymph nodes and/or could be due to lymphatic dissemination. In renal allograft recipient, most commonly TB occurs due to reactivation. In our case, it could have occurred by lymphatic spread from mediastinal lymphadenitis. Chest radiographs may fail to reveal any specific changes as was in our case. Traditionally, computed tomography (CT) has been used to diagnose sternal lesions; however, Atasoy et al. suggested the role of magnetic resonance imaging (MRI) for detecting early marrow and soft-tissue involvement due to high contrast resolution. 6 Although biopsy and culture of the Mycobacterium are considered as the gold standard, it has been demonstrated that fine needle aspiration cytology is the most commonly used technique for establishing a diagnosis which is easy and inexpensive. Deoxyribonucleic acid (DNA) detection by PCR for mycobacteria can be used along with traditional ZN staining for AFB, culture, and histopathology. There is no clear consensus regarding treatment. Majority of authors are of the opinion that standard anti-tubercular chemotherapy is sufficient, whereas some believe that surgical debridement with primary closure should be combined with extended chemotherapy. In renal allograft recipients, it gets even more difficult as adding rifampicin would warrant close monitoring of tacrolimus levels and may add to risk of acute rejections or even graft loss. Hence, rifampicin is avoided in countries like India. A four-drug regimen: pyrazinamide (three months); flouroquinolone (nine months); INH; and ethambutol (18-24 months) can be used. Surgical treatment can be decided based on the extent of bony destruction, associated complications, and response to therapy. Possible complications of sternal TB osteomyelitis include secondary infection, fistula formation, spontaneous fractures of the sternum, compression or erosion of the large blood vessels, compression of the trachea, and migration of TB abscess into the mediastinum, pleural cavity, or subcutaneous tissues. 7 In our patient, diagnosis of TB could be confirmed by radiological, histopathological, and microbiological investigations. The patient also had a prompt response to antitubercular therapy as demonstrated by resolution of symptoms. We assume that in our patient sternal TB could be as a result of reactivation of latent bacilli due to the immunosuppressive drugs. However, occurrence after 5 years of stable immunosuppression was surprising. Our case is just to emphasize the fact that a rare entity in the form of sternal TB can easily be diagnosed with high index of suspicion and has a favorable response to therapy in a renal allograft recipient.
